NBIIX
Price
$14.95
Change
-$0.12 (-0.80%)
Updated
Oct 7 closing price
Net Assets
1.13B
REREX
Price
$63.52
Change
-$0.34 (-0.53%)
Updated
Oct 7 closing price
Net Assets
138.4B
Interact to see
Advertisement

NBIIX vs REREX

Header iconNBIIX vs REREX Comparison
Open Charts NBIIX vs REREXBanner chart's image
Neuberger Berman International Eq I
Price$14.95
Change-$0.12 (-0.80%)
VolumeN/A
Net Assets1.13B
American Funds EUPAC R4
Price$63.52
Change-$0.34 (-0.53%)
VolumeN/A
Net Assets138.4B
NBIIX vs REREX Comparison Chart in %
View a ticker or compare two or three
VS
NBIIX vs. REREX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NBIIX is a StrongBuy and REREX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
REREX has more cash in the bank: 138B vs. NBIIX (1.13B). NBIIX pays higher dividends than REREX: NBIIX (1.60) vs REREX (0.68). NBIIX was incepted earlier than REREX: NBIIX (20 years) vs REREX (23 years). NBIIX (1.06) is less costly to investors than REREX (0.82). NBIIX is a more actively managed with annual turnover of: 64.00 vs. REREX (35.00). REREX has a lower initial minimum investment than NBIIX: REREX (250) vs NBIIX (1000000). REREX (10.07) and NBIIX (9.92) have marching annual gain over last year. REREX (13.55) and NBIIX (13.49) have equivalent 5 years return.
NBIIXREREXNBIIX / REREX
Total Expense Ratio0.890.82109%
Annual Report Gross Expense Ratio1.060.82129%
Fund Existence20 years23 years-
Gain YTD20.17521.43094%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.13B138B1%
Annual Yield % from dividends1.600.68236%
Returns for 1 year9.9210.0798%
Returns for 3 years52.9149.47107%
Returns for 5 years13.4913.55100%
Returns for 10 years49.3542.18117%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TELA1.570.06
+3.63%
TELA Bio
THM1.870.05
+2.75%
International Tower Hill Mines Ltd
VRDN21.000.17
+0.82%
Viridian Therapeutics
OACCU10.65N/A
N/A
Oaktree Acquisition Corp III Life Sciences
CRL170.10-4.85
-2.77%
Charles River Laboratories International